Experimental and Clinical Evidence for Ionic, Low-Osmolar Contrast Media for Thrombosis and Major Adverse Cardiac Event Reduction in the Setting of Percutaneous Coronary Intervention

Journal Supplement to March, 2010 Journal of Invasive Cardiology

Sponsored by North American Center for Continuing Medical Education, LLC

Presenters

Frederick Feit, MD
Associate Professor of Medicine
New York University School of Medicine
New York, New York

Roxana Mehran, MD
Associate Professor of Medicine
Joint Chief Scientific Offices, Clinical Trial Center
Columbia University
Cardiovascular Research Foundation
New York, New York

Steven V. Manoukian, MD, FACC, FSCAI
Director of Cardiovascular Research
Sarah Cannon Research Institute
Medical Director of Cardiology, Clinical Services Group
Hospital Corporation of America (HCA), Inc.
Interventional Cardiology
Centennial Heart
Nashville, Tennessee

Adriano Caixeta, MD, PhD
Postdoctoral Research Fellow
Center for Interventional Vascular Therapy
Columbia University Medical Center
Clinical Trial Center
Cardiovascular Research Foundation
New York, New York

Target Audience

This activity is designed for cardiologists, interventional cardiologists, nurses and radiologic technologists

Learning Objectives

Upon completion of this educational activity, participants should be able to:

• Describe the role of contrast agents in the setting of PCI.
• List the physical, chemical, and biological properties of contrast agents used in PCI and their potential impact on renal function, thrombosis, and bleeding.
• Explain how ionic properties, viscosity, and other chemical features may affect renal function and coagulation in the setting of PCI.
• Optimize selection of contrast agents in the cardiac catheterization laboratory in order to reduce potential adverse events.
• Initially risk stratify patients undergoing cath and determine which contrast agents may be uniquely suitable for specific patient subgroups.

Activity Overview

This accredited journal supplement is available in PDF format.

To be eligible for documentation of credit, participants must read all monograph content, complete the post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

There is no fee associated with this activity.

Release Date: March 1, 2010

Expiration Date: March 1, 2011  

Estimated time to complete: 2 hours

For questions regarding this activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s) ™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association. Provider #: 110-3-E-06.

This continuing nursing education activity was approved by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This continuing nursing education activity was approved for 2 contact hour(s). 

Provider approved by the California Board of Registered Nursing, Provider #13255 for 2 contact hour(s).

AHRA Accreditation

Approved for 1 Category A ARRT continuing education credit,

Independent Clinical Reviewer

Michael Wholey, MD, MBA
Dept of Cardiovascular and Interventional Radiology
University of Texas Health Science Center at San Antonio
San Antonio, Texas      

Planning Committee

The planning committee comprises Steven V. Manoukian, MD, FACC, FSCAI , Frederick Feit, MD, Roxana Mehran, MD, Adriano Caixeta, MD, PhD, and Michael Wholey, MD, MBA; Rich Keenan, Lindsay Mazzagatti, and Trish Levy, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity.  All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest.  If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
                
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Caixeta has disclosed no significant financial relationship with any commercial interest
Dr. Mehran: consultant--Guerbet, LLC
Dr. Feit has disclosed no significant financial relationship with any commercial interest
Dr. Manoukian:  consultant--Guerbet, LLC

Clinical Reviewer: Dr. Wholey:  no relevant financial relationships with any commercial interest
Editor: Renee Polvino: no relevant financial relationships with any commercial interest
Planning Committee members Rich Keenan, Lindsay Mazzagatti, and Trish Levy have reported no relevant financial relationships with any commercial interest.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Guerbet, LLC